Quality — FDA Registration Map

The world's strictest regulator trusts Indian pharma

Over 1,000 pharmaceutical facilities across India are registered with the United States Food and Drug Administration — the world's most demanding drug regulator. Each facility is subject to FDA inspection, documentation review, and compliance with Current Good Manufacturing Practice (cGMP). This is not a claim — it is the FDA's own public record.

1,030

FDA-Registered Facilities

States & Territories

530

API Manufacturers

552

Testing Laboratories

1,029 of 1,030 facilities mapped by PIN code centroid. State boundaries per Survey of India via Datameet open data. Facility coordinates are approximate (postal-area centroids, not exact addresses). Source: US FDA Establishment Registration data (public domain).

API Manufacture 530

Finished Dosage (FDF) 413

Analysis & Testing 552

Multi-operation

0 50 100 150 250

Telangana249

Gujarat203

Maharashtra158

Andhra Pradesh126

Karnataka85

Tamil Nadu47

Madhya Pradesh34

Himachal Pradesh28

Goa15

Haryana14

Uttarakhand14

Uttar Pradesh12

Punjab11

Dadra and Nagar Haveli and Daman and Diu8

Rajasthan8

Delhi7

Puducherry4

West Bengal4

Odisha1

Assam1

What this map means

🔬

Registered and inspectable

Every facility on this map is registered with the US FDA under 21 CFR Part 207. The FDA can inspect any of them at any time — and does. This is not voluntary; it is a legal condition of supplying the US market.

🏭

India's pharma heartland

Telangana (249), Gujarat (203), and Maharashtra (158) together account for over half of all FDA-registered facilities. These states form the backbone of India's pharmaceutical manufacturing ecosystem.

⚖️

API to finished dose

530 facilities manufacture active pharmaceutical ingredients (APIs) — the chemical compounds that make medicine work. 413 produce finished dosage forms. 552 run quality analysis and testing. Many facilities perform multiple operations.

🌎

Scale that matters

India has more FDA-registered pharmaceutical facilities than any country outside the United States. This infrastructure supplies affordable generic medicines to patients in over 200 countries — including one in three prescriptions dispensed in America.